[HTML][HTML] Vascular cognitive impairment–Past, present, and future challenges

A Badji, J Youwakim, A Cooper, E Westman… - Ageing Research …, 2023 - Elsevier
Vascular cognitive impairment (VCI) is a lifelong process encompassing a broad spectrum of
cognitive disorders, ranging from subtle or mild deficits to prodromal and fully developed …

Brain–body mechanisms contribute to sexual dimorphism in amyotrophic lateral sclerosis

SM Jacob, S Lee, SH Kim, KA Sharkey… - Nature Reviews …, 2024 - nature.com
Amyotrophic lateral sclerosis (ALS) is the most common form of human motor neuron
disease. It is characterized by the progressive degeneration of upper and lower motor …

Sex differences in plasma p-tau181 associations with Alzheimer's disease biomarkers, cognitive decline, and clinical progression

AA Tsiknia, SD Edland, EE Sundermann, ET Reas… - Molecular …, 2022 - nature.com
Studies have shown that women on the Alzheimer's disease (AD) continuum have more
pathological tau in the brain and cerebrospinal fluid (CSF), than men. Some studies have …

Plasma neurofilament light levels associate with muscle mass and strength in middle‐aged and older adults: Findings from GenoFit

J Pratt, G De Vito, R Segurado… - Journal of Cachexia …, 2022 - Wiley Online Library
Background Efforts to enhance diagnostic measures for sarcopenia have led to an
increased focus on the screening utility of blood‐based biomarkers. In this regard …

Validity of serum neurofilament light chain as a prognostic biomarker of disease activity in multiple sclerosis

MK Sen, MJ Hossain, DA Mahns, BJ Brew - Journal of Neurology, 2023 - Springer
Multiple sclerosis (MS) is a chronic demyelinating and neuroinflammatory disease of the
human central nervous system with complex pathoetiology, heterogeneous presentations …

Blood–brain barrier dysfunction in multiple sclerosis: Causes, consequences, and potential effects of therapies

B Zierfuss, C Larochelle, A Prat - The Lancet Neurology, 2024 - thelancet.com
Established by brain endothelial cells, the blood–brain barrier (BBB) regulates the trafficking
of molecules, restricts immune cell entry into the CNS, and has an active role in …

Blood‐brain barrier integrity impacts the use of plasma amyloid‐β as a proxy of brain amyloid‐β pathology

B Bellaver, A Puig‐Pijoan… - Alzheimer's & …, 2023 - Wiley Online Library
INTRODUCTION Amyloid‐β (Aβ) and tau can be quantified in blood. However, biological
factors can influence the levels of brain‐derived proteins in the blood. The blood‐brain …

Sex differences in behavioral symptoms and the levels of circulating GFAP, tau, and NfL in patients with traumatic brain injury

D Sass, VA Guedes, EG Smith, R Vorn… - Frontiers in …, 2021 - frontiersin.org
Traumatic brain injury (TBI) affects millions of Americans each year and has been shown to
disproportionately impact those subject to greater disparities in health. Female sex is one …

Blood–Brain Barrier Dysfunction and Aβ42/40 Ratio Dose-Dependent Modulation with the ApoE Genotype within the ATN Framework

S Toniolo, F Di Lorenzo, S Bernardini… - International Journal of …, 2023 - mdpi.com
The definition of Alzheimer's disease (AD) now considers the presence of the markers of
amyloid (A), tau deposition (T), and neurodegeneration (N) essential for diagnosis. AD …

Biological variation estimates for serum neurofilament light chain in healthy subjects

A Carobene, K Maiese, C Abou-Diwan, M Locatelli… - Clinica Chimica …, 2023 - Elsevier
Abstract Objectives Neurofilament light chain (NfL) is an emerging biomarker of
neurodegeneration disorders. Knowledge of the biological variation (BV) can facilitate …